Pharmacokinetics and biodistribution of radioimmunoconjugates of anti-CD19 antibody and single-chain Fv for treatment of human B-cell Malignancy Quanzhi LiWendy HudsonJohn H. Kersey ORIGINAL ARTICLE Pages: 121 - 130
Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen Ali SamanciQing YiHåkan Mellstedt ORIGINAL ARTICLE Pages: 131 - 142
Antitumor activity exhibited by Fas ligand (CD95L) overexpressed on lymphoid cells against Fas+ tumor cells Motomu ShimizuYasutaka TakedaAkio Matsuzawa ORIGINAL ARTICLE Pages: 143 - 148
Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2 Giovanni MantovaniVittorio GebbiaGiorgio Tore ORIGINAL ARTICLE Pages: 149 - 156
Adjuvant treatment of breast cancer: A pilot immunochemotherapy study with CMF, interleukin-2 and interferon alpha Giuseppe ToniniCorrado NunziataLiana De Vecchis ORIGINAL Pages: 157 - 166
Activation of EGF receptor family members suppresses the cytotoxic effects of tumor necrosis factor-α Michael HoffmannMathias SchmidtWinfried Wels ORIGINAL ARTICLE Pages: 167 - 175
The effect of recombinant human granulocyte/macrophage-colony-stimulating factor (rHu GM-CSF) and rHu G-CSF administration on neutrophil chemiluminescence assay in patients following cyclic chemotherapy Mutay AslanGultekin YucelBurhan Savas ORIGINAL ARTICLE Pages: 176 - 181